EP Wealth Advisors, LLC
- SEC CIK
- 0001540569
- Latest filing
- Aug 11, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by EP Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q2 2026)
- 38,135
- Value
- $3.11M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 38,135 | $3.11M | <0.1% | −271−0.7% | Reduced | Holders |
| Q1 2026 | 38,406 | $2.41M | <0.1% | −277−0.7% | Reduced | Holders |
| Q4 2025 | 38,683 | $2.57M | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 38,524 | $608.7K | <0.1% | +38,524 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −8,844−100.0% | Sold out | Holders |
| Q2 2024 | 8,844 | $229.9K | <0.1% | +25+0.3% | Added | Holders |
| Q1 2024 | 8,819 | $252.2K | <0.1% | +319+3.8% | Added | Holders |
| Q4 2023 | 8,500 | $260.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 8,500 | $228.4K | <0.1% | +7,607+851.8% | Added | Holders |
| Q2 2023 | 893 | $306.7K | <0.1% | −7,607−89.5% | Reduced | Holders |
| Q1 2023 | 8,500 | $215.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 8,500 | $344.8K | <0.1% | +8,500 | New | Holders |